Abstract 5911: The role of CD53+ subsets and the JAK/STAT3 pathway in regulating cancer stemness and immune escape in esophageal squamous cell carcinoma

Beilei Liu, Hongyu Zhou, Licheng Tan, Bowen Yao, Shuang Zhang, Jiayi Huang, Mengsu Yang, Xin‐Yuan GuanCancer 2025 · DOI

Abstract

T cell therapy has revolutionized treatment for hematologic malignancies but faces significant challenges in solid tumor applications, including esophageal squamous cell carcinoma (ESCC). In this study, we utilized a dynamic subcutaneous tumor growth model in mice to investigate how ESCC tumors modulate T cell activity through four distinct phases: initial enlargement, reduction, stabilization, and explosive growth. Single-cell sequencing revealed that CD53+ subsets were enriched in the reduction stage and showed their function in stemness regulation and immune escape. Functionally, CD53+ mouse ESCC cell lines showed a higher organoid formation ability when compared with CD53- cells. When co-cultured with T cells, CD53+ ESCC cell lines revealed their capability in regulating T cell exhaustion. Mechanically, GO enrichment analysis and western blotting demonstrated that CD53+ cells activated IL-6/JAK/STAT3 signaling pathways and upregulated their downstream genes such as C-myc and PD-L1. Furthermore, in vivo study showed that JAK inhibitor Ruxolitinib and STAT3 inhibitor C188-9 could efficiently reduce tumor growth and enhance T cell infiltration in CD53+ mouse ESCC cell lines, suggesting a role in tumor proliferation and T cell editing. This study aims to elucidate the biological function of CD53+ subset ESCC cells in tumor progression and verify their role in T cell regulation, offering new therapeutic targets for ESCC treatment. Citation Format: Beilei Liu, Hongyu Zhou, Licheng Tan, Bowen Yao, Shuang Zhang, Jiayi Huang, Mengsu Yang, Xinyuan Guan. The role of CD53+ subsets and the JAK/STAT3 pathway in regulating cancer stemness and immune escape in esophageal squamous cell carcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5911.
BibTeX
@inproceedings{liu2025abstract,
  author = {Beilei Liu and Hongyu Zhou and Licheng Tan and Bowen Yao and Shuang Zhang and Jiayi Huang and Mengsu Yang and Xin‐Yuan Guan},
  title = {{Abstract 5911: The role of CD53+ subsets and the JAK/STAT3 pathway in regulating cancer stemness and immune escape in esophageal squamous cell carcinoma}},
  booktitle = {Cancer},
  year = {2025},
  doi = {10.1158/1538-7445.am2025-5911},
}

Loading related content...

Figure